Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$217M |
| 2 |
JPMorgan Chase
JPM
|
+$213M |
| 3 |
Intel
INTC
|
+$200M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$184M |
| 5 |
TECD
Tech Data Corp
TECD
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$685M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$127M |
| 3 |
Meta Platforms (Facebook)
META
|
+$122M |
| 4 |
Merck
MRK
|
+$110M |
| 5 |
NVIDIA
NVDA
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.01% |
| 2 | Technology | 7.75% |
| 3 | Financials | 7.01% |
| 4 | Consumer Discretionary | 6.9% |
| 5 | Industrials | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Oracle
ORCL
$410B
| $23.8M | 0.03% |
431,027
+142,684
| +49% | +$7.56M |
|
|
CCXX.U
627
DELISTED
Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt
CCXX.U
| $23.8M | 0.03% |
2,102,783
-1,137,217
| -35% | -$11.9M |
|
628
Xylem
XYL
$26.7B
| $23.7M | 0.03% |
365,578
+231,141
| +172% | +$15.3M |
|
629
Bilibili
BILI
$6.91B
| $23.7M | 0.03% |
511,694
-496,717
| -49% | -$16.1M |
|
630
Agree Realty
ADC
$9.28B
| $23.7M | 0.03% |
360,384
-112,038
| -24% | -$7.15M |
|
|
631
NVIDIA
NVDA
$5.05T
| $23.7M | 0.03% |
2,492,360
-13,331,280
| -84% | -$108M |
|
|
NTCO
632
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
| $23.7M | 0.03% |
1,630,896
-148,722
| -8% | -$1.95M |
|
633
M&T Bank
MTB
$34.9B
| $23.6M | 0.03% |
227,221
+194,288
| +590% | +$20.5M |
|
634
ResMed
RMD
$33.5B
| $23.6M | 0.03% |
122,878
+59,995
| +95% | +$9.82M |
|
635
NCR Voyix
VYX
$1.1B
| $23.5M | 0.03% |
2,215,741
+2,197,405
| +11,984% | +$25.2M |
|
636
Zurn Elkay Water Solutions
ZWS
$8.1B
| $23.3M | 0.03% |
+1,659,177
| New | +$21.8M |
|
637
Euronet Worldwide
EEFT
$2.63B
| $23.2M | 0.03% |
242,416
+84,379
| +53% | +$7.79M |
|
638
GoDaddy
GDDY
$12.7B
| $23.2M | 0.03% |
316,516
+72,756
| +30% | +$5.23M |
|
|
AFMD
639
DELISTED
Affimed
AFMD
| $23.2M | 0.03% |
502,613
+279,507
| +125% | +$7.78M |
|
640
CALL
Target
TGT
$77.2B
| $23.2M | 0.03% |
193,100
+168,700
| +691% | +$19.3M |
|
|
HZNP
641
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $23.1M | 0.03% |
+415,376
| New | +$17.8M |
|
|
NVO
642
CALL
Novo Nordisk
NVO
$207B
| $22.9M | 0.03% |
+700,000
| New | +$22.3M |
|
643
CALL
Boeing
BA
$166B
| $22.8M | 0.03% |
124,400
| – | – |
|
644
Mercado Libre
MELI
$98.8B
| $22.8M | 0.03% |
23,121
+14,730
| +176% | +$11M |
|
645
SEI Investments
SEIC
$13.3B
| $22.8M | 0.03% |
413,865
-228,523
| -36% | -$11.9M |
|
646
Coca-Cola Europacific Partners
CCEP
$48.6B
| $22.7M | 0.03% |
601,108
+556,672
| +1,253% | +$21.8M |
|
647
Element Solutions
ESI
$8.52B
| $22.5M | 0.03% |
2,074,940
+2,041,545
| +6,113% | +$20.5M |
|
648
Owens Corning
OC
$11.6B
| $22.5M | 0.03% |
403,690
+305,558
| +311% | +$14.2M |
|
649
RenaissanceRe
RNR
$13.7B
| $22.5M | 0.03% |
131,487
+47,823
| +57% | +$7.85M |
|
|
MNTA
650
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $22.5M | 0.03% |
675,131
-79,939
| -11% | -$2.55M |
|
Similar funds
Israel Englander's Q2 2020 Portfolio in Review
As of Q2 2020, Israel Englander held 4,914 positions worth $73B, up 64% from $44.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander deployed $17.6B of net new capital in Q2 2020, opening 1,140 new positions and adding to 1,565 existing holdings. Its largest new stake was Global Payments: 1,008,446 shares worth $171M.
By sector, the portfolio is most concentrated in Healthcare at 9% of assets, down from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $127M trimmed.
- Israel Englander's largest Q2 2020 buy was Global Payments: 1,008,446 shares worth $171M.
- Israel Englander added most to Lowe's Companies in Q2 2020, an estimated $217M increase.
- Israel Englander's biggest Q2 2020 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $127M.
- Israel Englander fully exited Allergan plc in Q2 2020, selling an estimated $685M.
- Israel Englander's ten largest holdings make up 20% of its $73B portfolio in Q2 2020.
- Israel Englander opened 1,140 new positions and closed 798 in Q2 2020.
- Israel Englander's portfolio value rose 64% quarter-over-quarter to $73B.
Based on Millennium Management's 13F filing for Q2 2020, filed 14 Aug 2020.